Four independent studies demonstrate enantioselective synthesis of sulfinamidines, suggesting new medicinal applications.
Sulfinamidines are sulfur(IV) functional groups with significant medicinal potential and serve as versatile intermediates toward sulfur(VI) motifs, which are also of heightened pharmaceutical interest. However, their enantioselective synthesis has remained challenging, and catalytic asymmetric methods were absent. In late 2025, four independent studies reported the first catalytic enantioselective protocols. These advances boost the exploration of sulfinamidines for a variety of applications and establish a foundation for streamlined access to chiral sulfur(VI) species, including sulfondiimidamides and related motifs.
No takes yet. Share an insight, caveat, or question.
Fumito Saito (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: